Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Buy
61
CTBI Quote, Financials, Valuation and Earnings
Last price:
$64.72
Seasonality move
:
-1.23%
Day range:
$64.72 - $65.79
52-week range:
$44.60 - $65.70
Dividend yield:
3.05%
P/E ratio:
12.05x
P/S ratio:
2.90x
P/B ratio:
1.39x
Volume:
112.7K
Avg. volume:
74.8K
1-year change:
16.68%
Market cap:
$1.2B
Revenue:
$409.3M
EPS (TTM):
$5.43
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $237.4M | $255M | $324.7M | $374.4M | $409.3M | |
| Revenue Growth (YoY) | 4.4% | 7.43% | 27.34% | 15.31% | 9.32% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -$158K | -$168K | $996K | $631K | -- | |
| Operating Expenses | -$110.6M | -$101M | -$98.6M | -$106.7M | -$127.1M | |
| Operating Income | $110.6M | $101M | $98.6M | $106.7M | $127.1M | |
| Net Interest Expenses | $1.1M | $2M | $5.4M | $4.5M | -- | |
| EBT. Incl. Unusual Items | $110.6M | $101M | $98.6M | $106.7M | $127.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $22.7M | $19.2M | $20.6M | $23.9M | $29M | |
| Net Income to Company | $87.9M | $81.8M | $78M | $82.8M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $87.9M | $81.8M | $78M | $82.8M | $98.1M | |
| Basic EPS (Cont. Ops) | $4.94 | $4.59 | $4.36 | $4.61 | $5.44 | |
| Diluted EPS (Cont. Ops) | $4.94 | $4.58 | $4.36 | $4.61 | $5.43 | |
| Weighted Average Basic Share | $17.8M | $17.8M | $17.9M | $18M | $18M | |
| Weighted Average Diluted Share | $17.8M | $17.9M | $17.9M | $18M | $18M | |
| EBITDA | -- | $134.9M | $199.5M | $239.1M | -- | |
| EBIT | $125.7M | $129.7M | $194.1M | $234.1M | $253.8M | |
| Revenue (Reported) | $237.4M | $255M | $324.7M | $374.4M | $409.3M | |
| Operating Income (Reported) | $110.6M | $101M | $98.6M | $106.7M | $127.1M | |
| Operating Income (Adjusted) | $125.7M | $129.7M | $194.1M | $234.1M | $253.8M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $59.2M | $70.8M | $86.7M | $97.7M | $106.1M | |
| Revenue Growth (YoY) | 3.24% | 19.61% | 22.45% | 12.66% | 8.66% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -$208K | $117K | $258K | $521K | -- | |
| Operating Expenses | -$24.1M | -$26.2M | -$23.3M | -$29.3M | -$35.4M | |
| Operating Income | $24.1M | $26.2M | $23.3M | $29.3M | $35.4M | |
| Net Interest Expenses | $264K | $811K | $1.1M | $1.1M | -- | |
| EBT. Incl. Unusual Items | $24.1M | $26.7M | $23.3M | $29.3M | $35.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $4.9M | $4.3M | $4.6M | $6.8M | $8.1M | |
| Net Income to Company | $19.2M | $22.4M | $18.7M | $22.5M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $19.2M | $22.4M | $18.7M | $22.5M | $27.3M | |
| Basic EPS (Cont. Ops) | $1.08 | $1.26 | $1.04 | $1.25 | $1.51 | |
| Diluted EPS (Cont. Ops) | $1.08 | $1.26 | $1.04 | $1.25 | $1.51 | |
| Weighted Average Basic Share | $17.8M | $17.8M | $17.9M | $18M | $18M | |
| Weighted Average Diluted Share | $17.8M | $17.9M | $17.9M | $18M | $18.1M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $27.7M | $39.4M | $53.6M | $61.8M | $66.8M | |
| Revenue (Reported) | $59.2M | $70.8M | $86.7M | $97.7M | $106.1M | |
| Operating Income (Reported) | $24.1M | $26.2M | $23.3M | $29.3M | $35.4M | |
| Operating Income (Adjusted) | $27.7M | $39.4M | $53.6M | $61.8M | $66.8M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $237.1M | $254.7M | $324.4M | $374.4M | $408M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -$158K | -$168K | $996K | $631K | -- | |
| Operating Expenses | -$110.6M | -$100.5M | -$98.6M | -$106.7M | -$127.1M | |
| Operating Income | $110.6M | $100.5M | $98.6M | $106.7M | $127.1M | |
| Net Interest Expenses | $1.1M | $2M | $5.4M | $4.5M | $3M | |
| EBT. Incl. Unusual Items | $110.6M | $101M | $98.6M | $106.7M | $127.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $22.7M | $19.2M | $20.6M | $23.9M | $29M | |
| Net Income to Company | $87.9M | $81.8M | $78M | $82.8M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $87.9M | $81.8M | $78M | $82.8M | $98.1M | |
| Basic EPS (Cont. Ops) | $4.94 | $4.59 | $4.36 | $4.61 | $5.44 | |
| Diluted EPS (Cont. Ops) | $4.94 | $4.58 | $4.36 | $4.61 | $5.43 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $125.7M | $129.7M | $194.1M | $234.1M | $253.8M | |
| Revenue (Reported) | $237.1M | $254.7M | $324.4M | $374.4M | $408M | |
| Operating Income (Reported) | $110.6M | $100.5M | $98.6M | $106.7M | $127.1M | |
| Operating Income (Adjusted) | $125.7M | $129.7M | $194.1M | $234.1M | $253.8M | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $254.7M | $324.4M | $374.4M | $408M | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -$168K | $996K | $631K | $630K | -- | |
| Operating Expenses | -$100.5M | -$98.6M | -$106.7M | -$127.1M | -- | |
| Operating Income | $100.5M | $98.6M | $106.7M | $127.1M | -- | |
| Net Interest Expenses | $2M | $5.4M | $4.5M | $3M | -- | |
| EBT. Incl. Unusual Items | $101M | $98.6M | $106.7M | $127.1M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $19.2M | $20.6M | $23.9M | $29M | -- | |
| Net Income to Company | $81.8M | $78M | $82.8M | $46.9M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $81.8M | $78M | $82.8M | $98.1M | -- | |
| Basic EPS (Cont. Ops) | $4.59 | $4.36 | $4.61 | $5.44 | -- | |
| Diluted EPS (Cont. Ops) | $4.58 | $4.36 | $4.61 | $5.43 | -- | |
| Weighted Average Basic Share | $71.3M | $71.6M | $71.8M | $72.1M | -- | |
| Weighted Average Diluted Share | $71.4M | $71.6M | $71.9M | $72.2M | -- | |
| EBITDA | $29.5M | $42.6M | $56.4M | $60.6M | -- | |
| EBIT | $129.7M | $194.1M | $234.1M | $253.8M | -- | |
| Revenue (Reported) | $254.7M | $324.4M | $374.4M | $408M | -- | |
| Operating Income (Reported) | $100.5M | $98.6M | $106.7M | $127.1M | -- | |
| Operating Income (Adjusted) | $129.7M | $194.1M | $234.1M | $253.8M | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $46.6M | $51.3M | $58.8M | $73M | $62.9M | |
| Short Term Investments | $1.5B | $1.3B | $1.2B | $1.1B | -- | |
| Accounts Receivable, Net | $15.4M | $19.6M | $23.6M | $24.8M | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $330.9M | $152.2M | $296.8M | $398.2M | $65.9M | |
| Property Plant And Equipment | $52.6M | $59.7M | $61M | $64M | $68M | |
| Long-Term Investments | $281.1M | $89.3M | $222.6M | $323M | $10.3M | |
| Goodwill | $65.5M | $65.5M | $65.5M | $65.5M | -- | |
| Other Intangibles | $6.8M | $8.5M | $7.7M | $7.4M | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $5.4B | $5.4B | $5.8B | $6.2B | $6.7B | |
| Accounts Payable | $1M | $2.2M | $7.4M | $8.4M | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.6B | $1.6B | $4.3B | $4.7B | $1.8B | |
| Long-Term Debt | $70M | $73.9M | $78.9M | $77.6M | $81M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $4.7B | $4.8B | $5.1B | $5.5B | $5.8B | |
| Common Stock | $89.2M | $89.6M | $90M | $90.3M | -- | |
| Other Common Equity Adj | -$4.8M | -$129.2M | -$103.3M | -$98.4M | -- | |
| Common Equity | $698.2M | $628M | $702.2M | $757.6M | $856.1M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $698.2M | $628M | $702.2M | $757.6M | $856.1M | |
| Total Liabilities and Equity | $5.4B | $5.4B | $5.8B | $6.2B | $6.7B | |
| Cash and Short Terms | $1.8B | $1.4B | $1.4B | $1.4B | -- | |
| Total Debt | $70M | $73.9M | $79.1M | $77.7M | $81M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $46.6M | $51.3M | $58.8M | $73M | $62.9M | |
| Short Term Investments | $1.5B | $1.3B | $1.2B | $1.1B | -- | |
| Accounts Receivable, Net | $15.4M | $19.6M | $23.6M | $24.8M | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $330.9M | $152.2M | $296.8M | $398.2M | $65.9M | |
| Property Plant And Equipment | $52.6M | $59.7M | $61M | $64M | $68M | |
| Long-Term Investments | $281.1M | $89.3M | $222.6M | $323M | $10.3M | |
| Goodwill | $65.5M | $65.5M | $65.5M | $65.5M | -- | |
| Other Intangibles | $6.8M | $8.5M | $7.7M | $7.4M | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $5.4B | $5.4B | $5.8B | $6.2B | $6.7B | |
| Accounts Payable | $1M | $2.2M | $7.4M | $8.4M | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.6B | $1.6B | $4.3B | $4.7B | $1.8B | |
| Long-Term Debt | $70M | $73.9M | $78.9M | $77.6M | $81M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $4.7B | $4.8B | $5.1B | $5.5B | $5.8B | |
| Common Stock | $89.2M | $89.6M | $90M | $90.3M | -- | |
| Other Common Equity Adj | -$4.8M | -$129.2M | -$103.3M | -$98.4M | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $698.2M | $628M | $702.2M | $757.6M | $856.1M | |
| Total Liabilities and Equity | $5.4B | $5.4B | $5.8B | $6.2B | $6.7B | |
| Cash and Short Terms | $1.8B | $1.4B | $1.4B | $1.4B | -- | |
| Total Debt | $70M | $73.9M | $79.1M | $77.7M | $81M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $59.5M | $87.9M | $81.8M | $78M | $82.8M | |
| Depreciation & Amoritzation | $5.3M | $5M | $5.2M | $5.4M | $5M | |
| Stock-Based Compensation | $944K | $850K | $1.4M | $1.6M | $1.4M | |
| Change in Accounts Receivable | -$982K | $403K | -$4.2M | -$4M | -$1.2M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $62.4M | $115.7M | $99.7M | $85.7M | $105.2M | |
| Capital Expenditures | $3.2M | $19.6M | $6.2M | $13M | $8.1M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$693.5M | -$358.6M | -$280M | -$226.6M | -$335.7M | |
| Dividends Paid (Ex Special Dividend) | $27.1M | $27.9M | $29.9M | $32.2M | $33.4M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $25M | -- | $45M | $231.6M | $100M | |
| Long-Term Debt Repaid | -$25M | -$39K | -$45M | -$225.2M | -$100.2M | |
| Repurchase of Common Stock | $1.1M | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $704.7M | $216.4M | -$2.7M | $283.6M | $328.6M | |
| Beginning Cash (CF) | $264.7M | $338.2M | $311.8M | $128.7M | $271.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $73.6M | -$26.5M | -$183.1M | $142.7M | $98.1M | |
| Ending Cash (CF) | $338.2M | $311.8M | $128.7M | $271.4M | $369.5M | |
| Levered Free Cash Flow | $59.2M | $96.1M | $93.5M | $72.7M | $97.1M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $19.2M | $22.4M | $18.7M | $22.5M | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | $214K | $358K | $424K | $333K | -- | |
| Change in Accounts Receivable | -$135K | -$3.1M | -$2.1M | -$988K | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $33.8M | $27.3M | $20M | $22.4M | -- | |
| Capital Expenditures | $558K | $1.9M | $8M | $3M | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $50M | -$27M | -$49.2M | -$124.4M | -- | |
| Dividends Paid (Ex Special Dividend) | $7.1M | $7.9M | $8.2M | $8.4M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $25M | -- | -- | -- | |
| Long-Term Debt Repaid | -$10K | -$25M | -$94K | -$63K | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $20.2M | -$131.2M | $81.4M | $230.5M | -- | |
| Beginning Cash (CF) | $207.8M | $259.6M | $219.3M | $240.9M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $104M | -$130.9M | $52.1M | $128.6M | -- | |
| Ending Cash (CF) | $311.8M | $128.7M | $271.4M | $369.5M | -- | |
| Levered Free Cash Flow | $33.2M | $25.4M | $12M | $19.4M | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $87.9M | $81.8M | $78M | $82.8M | -- | |
| Depreciation & Amoritzation | $5M | $5.2M | $5.4M | $5M | -- | |
| Stock-Based Compensation | $850K | $1.4M | $1.6M | $1.4M | -- | |
| Change in Accounts Receivable | $403K | -$4.2M | -$4M | -$1.2M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $115.7M | $99.7M | $85.7M | $105.2M | -- | |
| Capital Expenditures | $19.6M | $6.2M | $13M | $8.1M | $24.7M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$358.6M | -$280M | -$226.6M | -$335.7M | -- | |
| Dividends Paid (Ex Special Dividend) | $27.9M | $29.9M | $32.2M | $33.4M | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $45M | $231.6M | $100M | -- | |
| Long-Term Debt Repaid | -$39K | -$45M | -$225.2M | -$100.2M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $216.4M | -$2.7M | $283.6M | $328.6M | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$26.5M | -$183.1M | $142.7M | $98.1M | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $96.1M | $93.5M | $72.7M | $97.1M | -- | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $81.8M | $78M | $82.8M | $46.9M | -- | |
| Depreciation & Amoritzation | $1.3M | $907K | $1.1M | $2.8M | -- | |
| Stock-Based Compensation | $1.4M | $1.6M | $1.4M | $1.3M | -- | |
| Change in Accounts Receivable | -$4.2M | -$4M | -$1.2M | $303K | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $99.7M | $85.7M | $105.2M | $90.1M | -- | |
| Capital Expenditures | $6.2M | $13M | $8.1M | $24.7M | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$280M | -$226.6M | -$335.7M | -$286.2M | -- | |
| Dividends Paid (Ex Special Dividend) | $29.9M | $32.2M | $33.4M | $26.4M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $45M | $231.6M | $100M | $100M | -- | |
| Long-Term Debt Repaid | -$45M | -$225.2M | -$100.2M | -$100.2M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$2.7M | $283.6M | $328.6M | $334.2M | -- | |
| Beginning Cash (CF) | $949.5M | $693.4M | $967.3M | $710.2M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$183.1M | $142.7M | $98.1M | $138.1M | -- | |
| Ending Cash (CF) | $766.5M | $836.1M | $1.1B | $736M | -- | |
| Levered Free Cash Flow | $93.5M | $72.7M | $97.1M | $65.3M | -- | |
Get CTBI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CTBI
Sector
P/E ratio
12.05x
12.54x
PEG ratio
0.67x
0.32x
P/B ratio
1.39x
1.15x
Price / LTM sales
2.90x
1.86x
Growth Metrics
CTBI
Sector
Revenue growth
8.66%
5.54%
Earnings growth
20.9%
11.36%
Revenue (5-year growth)
12.48%
8.68%
Earnings forecast
$1.43
$0.64
Profitability
CTBI
Sector
Profitability FY 2025
--
--
Return on invested capital
8.53%
5.2%
Return on assets
1.52%
1.03%
Return on equity
12.15%
9.91%
Earnings Date
Last Earnings Date
Jan
21
Next Earnings Date
Apr
22
Estimated Next Earnings Date
Apr
22
Balance Sheet
CTBI
Sector
Total cash
$984.8M
$407.2M
Short term investments
$1.1B
$192.4M
Total assets
$6.7B
$3.1B
Long term debt
$81M
$59.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
53
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 30x
Alerts
Sell
43
BILL alert for Feb 10
Bill Holdings, Inc. [BILL] is up 3.7% over the past day.
Buy
75
PRLB alert for Feb 9
Proto Labs, Inc. [PRLB] is down 2.16% over the past day.
Sell
30
MSTR alert for Feb 9
Strategy, Inc. [MSTR] is up 2.59% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
